153 related articles for article (PubMed ID: 300090)
1. Characterization of DNA used to assay sera for anti-DNA antibodies; determination of the specificities of anti-DNA antibodies in SLE and non-SLE rheumatic disease states.
Locker JD; Medof ME; Bennett RM; Sukhupunyaraksa S
J Immunol; 1977 Feb; 118(2):694-701. PubMed ID: 300090
[TBL] [Abstract][Full Text] [Related]
2. Effect of incomplete double strandedness of test DNA on DNA binding results.
Medof ME
J Lab Clin Med; 1982 Mar; 99(3):410-7. PubMed ID: 7057066
[TBL] [Abstract][Full Text] [Related]
3. The significance of antibodies to poly(adenosine diphosphate-ribose) in systemic lupus erythematosus.
Okolie EE; Shall S
Clin Exp Immunol; 1979 Apr; 36(1):151-64. PubMed ID: 313859
[TBL] [Abstract][Full Text] [Related]
4. [Determination of anti dsDNA antibodies by immunofluorescence using Crithidia luciliae. I--Diagnostic and prognostic value in systemic lupus erythematosus. Comparison with the Farr radioimmunoassay].
Borda-Iriarte O; Meyer O; Cyna J; Haïm T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):185-91. PubMed ID: 6374861
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of anti double-stranded and single-stranded DNA antibodies measurements by enzyme-linked immunosorbent assay (ELISA) using E. coli plasmid DNA].
Miyawaki S; Mineshige H; Kawamura M
Rinsho Byori; 1992 Oct; 40(10):1073-9. PubMed ID: 1307611
[TBL] [Abstract][Full Text] [Related]
6. [Absence of anti double stranded DNA antibodies in viral hepatitis (author's transl)].
Monier JC; Perraud M; Chevallier PH; Sepetjan M; Trepo C
Nouv Presse Med; 1979 Jun; 8(29):2395-8. PubMed ID: 493025
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a monoclonal and polyclonal anti-idiotype against a human IgG anti-DNA antibody.
Ehrenstein MR; Hartley B; Wilkinson LS; Isenberg DA
J Autoimmun; 1994 Jun; 7(3):349-67. PubMed ID: 7916908
[TBL] [Abstract][Full Text] [Related]
8. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
9. Crossreactivity of antiphospholipid antibodies.
Harris EN; Gharavi AE; Loizou S; Derue G; Chan JK; Patel BM; Mackworth-Young CG; Bunn CC; Hughes GR
J Clin Lab Immunol; 1985 Jan; 16(1):1-6. PubMed ID: 3981615
[TBL] [Abstract][Full Text] [Related]
10. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA.
Gripenberg M; Helve T; Kurki P
J Rheumatol; 1985 Oct; 12(5):934-9. PubMed ID: 3878880
[TBL] [Abstract][Full Text] [Related]
11. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
Rauch J; Massicotte H; Tannenbaum H
J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
[TBL] [Abstract][Full Text] [Related]
12. Clinical importance of antibodies against double-stranded ribonucleic acid in systemic lupus erythematosus and similar diseases of connective tissue.
Cebecauer L; Rovenský J; Poverenny AM; Podgorodnichenko VK; Doskocil J; Zitnan D
Czech Med; 1979; 2(3):134-40. PubMed ID: 535500
[TBL] [Abstract][Full Text] [Related]
13. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders].
Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
15. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
[TBL] [Abstract][Full Text] [Related]
16. [Anti-DNA antibodies: structure and pathogenic role].
Ayed K
Arch Inst Pasteur Tunis; 2000; 77(1-4):3-9. PubMed ID: 14658221
[TBL] [Abstract][Full Text] [Related]
17. Deoxyribonucleic acid strandedness. Partial characterization of the antigenic regions binding antibodies in lupus erythematosus serum.
Samaha RJ; Irvin WS
J Clin Invest; 1975 Aug; 56(2):446-57. PubMed ID: 125288
[TBL] [Abstract][Full Text] [Related]
18. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus.
Stevenson FK; Longhurst C; Chapman CJ; Ehrenstein M; Spellerberg MB; Hamblin TJ; Ravirajan CT; Latchman D; Isenberg D
J Autoimmun; 1993 Dec; 6(6):809-25. PubMed ID: 8155258
[TBL] [Abstract][Full Text] [Related]
19. [Kinetoplast of the flagellate crithidia luciliae: a suitable substrate for the detection of antibodies to native, double-stranded DNA in the indirect immuno-fluorescence test (author's transl)].
Stingl G; Knapp W
Wien Klin Wochenschr; 1975 Dec; 87(24):827-9. PubMed ID: 775803
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
